Immunocore is a leading T cell receptor (TCR) biotechnology company working to create first-in-class biological therapies to address unmet patient needs in oncology as well as infectious and autoimmune diseases.
See our community guidelines: http://bit.ly/2kFA8hr
Location: United Kingdom, England, Abingdon
Employees: 201-500
Total raised: $1.02B
Founded date: 2008
Investors 6
| Date | Name | Website |
| - | Terra Magn... | terramagnu... |
| - | NeoMed Man... | neomed.net... |
| - | T1D Fund | t1dfund.or... |
| - | Omega Fund... | omegafunds... |
| - | General At... | generalatl... |
| - | Avego | avego.com |
Funding Rounds 6
| Date | Series | Amount | Investors |
| 18.07.2022 | - | $140M | - |
| 09.02.2021 | - | $312.1M | - |
| 11.01.2021 | Series C | $75M | - |
| 19.03.2020 | Series B | $131.71M | - |
| 18.09.2017 | - | $40M | - |
| 29.07.2015 | - | $320M | - |
Mentions in press and media 28
| Date | Title | Description | Source |
| 27.03.2024 | Meet the companies that raised the top 7 UK funding rounds i... | Read this article in: Funding is the backbone for the remarkable growth of startups in many countrie... | siliconcan... |
| 05.03.2024 | Immunocore presented two posters at CROI 2024 | - | globenewsw... |
| 01.03.2024 | Oncobit joins forces with Immunocore | Oncobit is a medtech spin-off from the University Hospital of Zurich, that has developed a scalable ... | startuptic... |
| 02.12.2022 | Immunocore and Gadeta Announce Agreement to Develop First Ga... | Immunocore and Gadeta Announce Agreement to Develop First Gamma Delta (γδ) TCR ImmTAC for Solid Tumo... | einpresswi... |
| 09.11.2022 | Medison Pharma Announces Expansion of the Multi-Territorial ... | With this latest expansion, Medison's global footprint is now extended across Israel, Central and Ea... | en.prnasia... |
| 18.07.2022 | Immunocore Announces $140 Million Private Placement Financin... | PRESS RELEASE Immunocore Announces $140 Million Private Placement Financing (OXFORDSHIRE, England &a... | globenewsw... |
| 08.06.2022 | Medison Pharma Announces the Approvals by Health Canada and ... | KIMMTRAK has been approved in Canada and Australia for the treatment of an aggressive form of ocular... | en.prnasia... |
| 23.05.2022 | Medison Pharma Announces Extension of Multi-territorial Agre... | The latest geographic growth increases Medison's global footprint across 25 countries in four contin... | en.prnasia... |
| 11.08.2021 | Immunocore Reports Second Quarter 2021 Financial Results and... | Immunocore Holdings plc (Nasdaq: IMCR), a late-stage biotechnology company pioneering the developmen... | neomed.net... |
| 25.03.2021 | Immunocore Provides Business Update and Reports Full Year 20... | Immunocore (Nasdaq: IMCR), a late-stage biotechnology company pioneering the development of a novel ... | neomed.net... |
Show more